Α-Methylserotonin

• none

• Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries)

• 3-(2-aminopropyl)-1H-indol-5-ol

• 304-52-9 ^Y

• 2107

• 152

• 2023 ^Y

• 5Y83TBC5NM

• CHEBI:48295 ^Y

• ChEMBL275854 ^Y

• DTXSID10657549

• Interactive image

• c2cc(O)cc1c2[nH]cc1CC(N)C

• InChI=1S/C11H14N2O/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11/h2-3,5-7,13-14H,4,12H2,1H3 ^Y
• Key:LYPCGXKCQDYTFV-UHFFFAOYSA-N ^Y

Legal status

United States

Florida

See also

References

1. ^ Ismaiel AM, Titeler M, Miller KJ, Smith TS, Glennon RA (February 1990). "5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin". Journal of Medicinal Chemistry. 33 (2): 755–8. doi:10.1021/jm00164a046. PMID 2299641.
2. ^ ^{a b c} "Erowid Online Books : "TIHKAL" - #48 a-MT".
3. ^ Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL (January 1990). "A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model". Journal of Cerebral Blood Flow and Metabolism. 10 (1): 1–12. doi:10.1038/jcbfm.1990.2. PMID 2298826.
4. ^ ^{a b} Sourkes TL, Montine TJ, Missala K (1990). "Alpha-methylserotonin, a substitute transmitter for serotonergic neurons". Progress in Neuro-psychopharmacology & Biological Psychiatry. 14 (5): 829–32. doi:10.1016/0278-5846(90)90055-l. PMID 1705718. S2CID 25604266.
5. ^ ^{a b} Sourkes TL (1991). "Alpha-methyltryptophan as a therapeutic agent". Progress in Neuro-psychopharmacology & Biological Psychiatry. 15 (6): 935–8. doi:10.1016/0278-5846(91)90020-2. PMID 1763198. S2CID 31504647.
6. ^ "Erowid Online Books : "TIHKAL" - #5. a,O-DMS".
7. ^ "§1308.11 Schedule I." Archived from the original on 2009-08-27. Retrieved 2014-12-17.
8. ^ Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL